NRX NurExone Biologic Inc.
0.3425USD0.4900 CAD · TSXV+2.08%Mkt Cap: 31.53M USDP/E: —1d ago
NurExone Biologic Inc., a pharmaceutical technology company, develops a platform for biologically guided exosome-based therapies for the treatment of central nervous system injuries. It offers ExoPTEN, for treatment of acute spinal cord injuries. The company was founded in 2020 and is based in Toronto, Canada.…